Call for Abstract

23rd International Conference on Diabetes, Nutrition, Obesity and Eating Disorders, will be organized around the theme “Theme: Innovations in Diabetes Management and Nutritional Strategies”

Diabetic Nutrition 2024 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Diabetic Nutrition 2024

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Type 1 diabetes is primarily characterized by the immune-mediated destruction of insulin-producing pancreatic cells. It was traditionally considered a disease that primarily affected children and adolescents, but this perception has changed over the past decade as the age of symptomatic onset is no longer a limiting factor. 

Type 2 diabetes, previously known as non-insulin-dependent diabetes or adult-onset     diabetes, is the most common form of diabetes, accounting for at least 90% of all cases. It is characterized by insulin resistance, where the body's cells do not respond effectively to insulin, and relative insulin deficiency, which means that the body does not produce enough insulin or cannot use it properly.

 

An underlying health condition characterized by an excessive accumulation of body fat is often the cause of obesity. It has an adverse impact on health, particularly by increasing the chance of developing other chronic conditions including diabetes and heart disease. A BMI of more than 30 kg/m2 is considered obese. One of the most common illnesses in developed countries is obesity, and the incidence of this condition is increasing.

 

There are still a lot of people in the globe who don't know what genetic diabetes is. This leads to a variety of issues since it enables people to enter pre-diabetic phase without ever realizing it. A genetic predisposition to diabetes is caused by variables that are activated by genetics. Diabetes is a condition that is related to individuals from birth and is brought on by external factors. But this isn't always the case. The diabetic circumstances could be defined by other events. The steps and therapies that need to be followed in order to prevent genetic Diabetes will be covered in this genetic Diabetes presentation.

         

Although the amount of glucose ingested varies greatly, living organisms rely on hormones produced by the endocrine glands to maintain stable blood sugar level throughout life. Normal blood sugar levels are achieved by the release of hormones into the blood that activate signalling pathways. Because the endocrine system is an important part of our body, a lot of research is being done on it. Better knowledge of the endocrine system will allow us to develop new strategies to prevent diseases such as diabetes.

Endocrinology, Molecules and Cells The study of hormones, endocrine glands, and atomic structures is the focus of cellular and molecular endocrinology. The study of calcium's role in bone metabolism, thyroid problems, atherosclerosis, and muscle metabolism is a major focus of cellular and molecular endocrinology. This presentation reviews DNA technology and its applications in several industries. The main goal of this session is to apply the latest discoveries and techniques in cellular and molecular endocrinology to endocrine problems. Technology using recombinant DNA Pathophysiology of Diabetes T1DM is an autoimmune disease Insulin Resistance T2DM.


 

 

Treating and preventing diabetes requires diet and consistent exercise. The body's metabolism, which normally functions normally, is also affected by diabetes. A patient's abnormal metabolism affects every part of the body. Metabolic disorders cause problems with insulin synthesis and receptors, making diabetes a chronic disease. In this lecture, we will look at the nutritional and metabolic components of diabetes. nutrition in infancy Impact of dietary changes and traditional treatments on diabetes.

 The diabetes market has changed significantly over the past two decades due to innovations and advancements in treatments. Drug developers have found this market to be a lucrative one because the disease is so common and the number of patients is expected to increase in the near future. As a result, the global market size, as measured by pharmaceutical sales, has grown six-fold since 2000, according to Global Data, a renowned data and analytics firm. The growth rate (CAGR) will increase by 6.5% from $19.7 billion in 2020 to $27 billion in 2025.

 

 

 Many common herbs and spices are believed to have blood sugar-lowering properties, making them beneficial for people who have or are at high risk for type 2 diabetes. Recent clinical trials have revealed a potential link between herbal remedies and better blood sugar control, leading to increased use of these “natural” substances by people with diabetes as a means of managing their condition.

 

The goal of treatment is to keep blood sugar levels within a specific range. You can achieve this by eating well, exercising as much as possible, and getting regular check-ups. Some people may need regular blood sugar testing and the use of insulin or other medications. Blood sugar levels are affected by diabetes treatment The goal of treatment is to keep blood sugar levels within a specific range. You can achieve this by eating well, exercising as much as possible, and getting regular check-ups. 

Common signs of diabetes include:

  • Urinating frequently
  • Extreme thirst
  • Feeling more tired than usual
  • Lose weight naturally
  • Vaginal itching or thrush Cuts and wounds take longer to heal
  •  Blurry vision
     

 

 In this study, autologous hematopoietic stem cells were used. It is the same as stem cells collected from umbilical cord blood. Type 1 diabetes, also called juvenile diabetes, is an autoimmune disease that affects young children, so we understand how the research could help people who store cord blood after birth. The healthy blood type is cord blood.Dietary goals for patients with diabetes have become more patient-centred and adaptive over time.

In addition to eating right, exercise is also important. Participate in as many activities as possible, in as many different situations as possible. Try to get at least 30 minutes of moderate-intensity exercise most, if not all, days. Regular 30 minutes of physical activity helps lower blood sugar and cholesterol levels. lower blood pressure Reduce anxiety and tension Strengthen your confidence and mood. Improves sleep quality. Strengthens muscles and bones. Diabetes and Physical Activity in addition to eating right, exercise is also important.

An epidemic of eating disorders? It is known that up to 30%        of people with type 1 diabetes suffer from an eating disorder. People with type 1 diabetes are twice as likely to develop eating disorders compared to people without type 1 diabetes. Binge eating disorder is thought to affect 5-9% of people. An epidemic of eating disorders? It is known that up to 30% of people with type 1 diabetes suffer from an eating disorder. People with type 1 diabetes are twice as likely to develop eating disorders compared to people without type 1 diabetes. 

 

 

If you are concerned that you may have an eating disorder, it is important to know the warning signs so you can get appropriate help when you need it. This information is also for friends or family members who are concerned that someone with diabetes may develop an eating disorder. Here are some indicators of an eating disorder: Elevated HbA1c levels or frequently fluctuating blood sugar levels approaching or approaching diabetic ketoacidosis (DKA) Introduce extreme restrictions in your diet.

 

 

 Eating disorders can affect anyone at any time. This doesn't just affect people with diabetes. Their beginnings are complex and unique for each person. Some people experience depression and end up overeating to feel comfortable, while others develop an obsession with food due to external pressures. You can experience: I don't like the way I look Your life has become unmanageable. Diabetes is a condition in which blood sugar levels become abnormal and begin to take control of your life, making you feel unhappy, anxious, pressured, or controlled by others.

 

Checking the potential of diabetes research depends on a critical component: assessment of the clinical situation. This element not only improves global health outcomes, but also promotes the dissemination of key best practices by providing valuable scientific information through case studies. By conducting rigorous, context-specific assessments, we are paving the way for the rapid adoption of cutting-edge medical innovations, such as transplantation and integrative care, in hospital settings. Additionally, a better understanding of glycaemic index and load can help identify underlying diseases or conditions, such as cortisol dysregulation, which could revolutionize diabetes diagnosis and treatment.

Diabetes research and clinical practice are rapidly evolving, revealing many new therapeutic targets. Among these, incretion-based therapies such as GLP-1 incretions and GLP-1 and DPP4, as well as oral therapies such as insulin secretagogues, are promising. Additionally, advances in the field include new developments such as the regeneration and expansion of pancreatic islet cells and the treatment of microbial infections. Technologies such as embryonic stem cell and fatal precursor cell transplantation and stem cell therapy have also emerged as effective methods in the treatment of diabetes. In addition to these new treatments, Chinese medicine also plays an important role in diabetes treatment. 

Globally, the prevalence of diabetes has reached epidemic proportions, with  642 million people expected to have diabetes by 2040. Diabetes cases around the world. To further complicate this issue, having kidney disease significantly increases the risk of cardiovascular complications and death in people with diabetes. In response to these pressing issues, innovative conferences have been convened to address the pressing issues facing vulnerable populations. The purpose of the meeting is to explore optimal glycaemic control, the safety profile of current diabetes treatments, and the challenges of developing new treatments aimed at improving renal function and cardiovascular outcomes. 

When grappling with type 1 diabetes, the body faces a critical challenge: the inability to    produce any insulin whatsoever. This arises from a relentless assault by the immune system on the insulin-producing cells, leading to their destruction. As a result, type 1 diabetes earns its classification as an autoimmune condition, marking a distinct pathophysiological origin.In stark contrast, type 2 diabetes unfolds through a different narrative. Here, the body struggles to generate an adequate supply of insulin or encounters difficulties in its proper utilization. This intricate dance between insulin production and efficacy can stem from a myriad of factors, setting type 2 diabetes apart from its autoimmune counterpart.